Zhonghua Yi Xue Za Zhi
[The impact of KIT and other concomitant gene mutations on the prognoses of patients with core-binding factor acute myeloid leukemia].
Wang F, Wang W, Liu M, Zhang Y, Chen X, Yuan LL, Ma XL, Nie DJ, Wang MY, Zhang Y, Zhang W, Liu MY, Liu HX
Objective: To study the impact of KIT and other concomitant gene mutations on the prognoses of patients with core-binding factor acute myeloid leukemi ...
Read More
Source: PubMed
Exp. Hematol. 2020 Jan 30
Tracking HSCs and their progeny using whole genome sequencing.
Lee-Six H, Kent DG
Despite decades of progress in our understanding of hematopoiesis through the study of animal models and transplantation in humans, investigating phys ...
Read More
Source: PubMed
Am. J. Ophthalmol. 2020 Jan 29
Ocular Complications in School-Age Children and Adolescents after Allogeneic Bone Marrow Transplantation.
Hoehn ME, Vestal R, Calderwood J, Gannon E, Cook B, Rochester R, Hartford C, Triplett B, Sunkara A, Kang G, Walton RC
Determine the ocular complications in school-age children and adolescents surviving at least one year following allogeneic bone marrow transplantation ...
Read More
Source: PubMed
Clin. Exp. Med. 2020 Jan 31
Prognostic significance of serum progranulin level in de novo adult acute lymphoblastic leukemia patients.
El-Ghammaz AMS, Azzazi MO, Mostafa N, Hegab HM, Mahmoud AA
Increased expression of progranulin (PGRN) has been reported in some hematological cancers, but limited information regarding its significance in acut ...
Read More
Source: PubMed
Bone Marrow Transplant. 2020 Jan 31
CD19/CD22 chimeric antigen receptor T-cell therapy for refractory acute B-cell lymphoblastic leukemia with FLT3-ITD mutations.
Jin A, Feng J, Wei G, Wu W, Yang L, Xu H, Zhang Y, Cui J, Chang AH, Hu Y, Huang H
Treatment of acute lymphoblastic leukemia (ALL) is still a challenge despite years of researching, especially for those of poor prognosis. Zhang and h ...
Read More
Source: PubMed
